Abbvie Reports Better-than-expected 4q On Humira Sales

Drugmaker Abbvie posted better-than-expected adjusted results for the fourth quarter on Friday due to double-digit growth of its blockbuster anti-inflammatory drug Humira. … Click to Continue »

BING NEWS:
  • AbbVie Q1 report beats Street despite plunging Humira sales
    AbbVie (ABBV) stock slid nearly 4% Friday, despite the drugmaker reporting better-than-expected Q1 earnings. Read more here.
    04/26/2024 - 4:20 am | View Link
  • AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
    AbbVie said it expects adjusted earnings in 2024 of between $11.13 and $11.33 a share, up from previous guidance of $10.97 to $11.17 a share. Analysts surveyed by FactSet were expecting full-year ...
    04/26/2024 - 2:58 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News